Noritaka Machii
Fukushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study.
Journal: BMJ open diabetes research & care
Published: December 30, 2022
Burden of Undiagnosed Type 2 Diabetes in Diabetic Kidney Disease: A Japanese Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: May 31, 2020
Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: May 19, 2020
Walking Speed is the Sole Determinant Criterion of Sarcopenia of Mild Cognitive Impairment in Japanese Elderly Patients with Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine
Published: April 13, 2020
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial.
Journal: Journal of diabetes investigation
Published: March 24, 2020
High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes.
Journal: Scientific reports
Published: February 02, 2020
Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population.
Journal: Scientific reports
Published: September 15, 2019
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.
Journal: Cardiovascular diabetology
Published: February 28, 2017
The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.
Journal: Journal of medical case reports
Published: April 21, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026